Bank of New York Mellon’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.58M | Buy |
|
|||||
|
2025
Q2 | $1.76M | Buy |
|
|||||
|
2025
Q1 | $1.98M | Buy |
|
|||||
|
2024
Q4 | $1.09M | Sell |
|
|||||
|
2024
Q3 | $938K | Sell |
|
|||||
|
2024
Q2 | $964K | Buy |
|
|||||
|
2024
Q1 | $770K | Sell |
|
|||||
|
2023
Q4 | $871K | Sell |
|
|||||
|
2023
Q3 | $768K | Sell |
|
|||||
|
2023
Q2 | $1.11M | Buy |
|
|||||
|
2023
Q1 | $670K | Buy |
|
|||||
|
2022
Q4 | $546K | Sell |
|
|||||
|
2022
Q3 | $642K | Buy |
|
|||||
|
2022
Q2 | $579K | Buy |
|
|||||
|
2022
Q1 | $245K | Hold |
|
|||||
|
2021
Q4 | $281K | Buy |
|
|||||
|
2021
Q3 | $135K | Buy |
|
|||||
|
2021
Q2 | $177K | Sell |
|
|||||
|
2021
Q1 | $747K | Sell |
|
|||||
|
2020
Q4 | $818K | Buy |
|
|||||
|
2020
Q3 | $684K | Buy |
|
|||||
|
2020
Q2 | $273K | Buy |
|
|||||
|
2020
Q1 | $195K | Buy |
|
|||||
|
2019
Q4 | $588K | Buy |
|
|||||
|
2019
Q3 | $754K | Sell |
|
|||||
|
2019
Q2 | $3.49M | Buy |
|
|||||
|
2019
Q1 | $2.96M | Buy |
|
|||||
|
2018
Q4 | $339K | Buy |
|
|||||
|
2018
Q3 | $262K | Buy |
|